<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00675272</url>
  </required_header>
  <id_info>
    <org_study_id>KUH5070197</org_study_id>
    <nct_id>NCT00675272</nct_id>
  </id_info>
  <brief_title>Organ Donation and Hydrocortisone Treatment</brief_title>
  <acronym>HYDRO</acronym>
  <official_title>Organ Donation and Vasopressor Use: Effects of Hydrocortisone Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kuopio University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Brain death patients who are selected for organ donation very often suffer from haemodynamic
      instability. To treat this, high amounts of vasoactive drugs(norepinephrine) may be needed to
      raise blood pressure. However,norepinephrine may have negative influence on several organs
      causing reduced blood flow ischemia. Our hypothesis is that hydrocortisone treatment may
      reduce the amount of vasoactive drugs needed to keep the blood pressure stable in patients
      selected for organ donation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      When patients are treated in the ICU only as possible organ donators they will be assessed
      for eligibility for the study. Iv hydrocortisone or placebo will be administered every 6
      hours. Several hormonal samples will be collected.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Routine use of corticoids became standard therapy
  </why_stopped>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>dosage and time on norepinephrine treatment</measure>
    <time_frame>in ICU</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hormone levels and number of organs donated</measure>
    <time_frame>Hospital treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Brain Death</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>hydrocortisone treatment 50mg iv x4</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo iv every 6 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hydrocortisone</intervention_name>
    <description>hydrocortisone 50mg iv. every 6 hours</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sodium chloride</intervention_name>
    <description>sodium chloride every 6 hours iv</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: all have to be fulfilled

          -  severe brain injury or subarachnoid hemorrhage which progrediates to brain death and
             patients are treated only as candidates for organ donation in the ICU

          -  no other reasons for treatment than organ donation

          -  informed consent from official representative

        Exclusion Criteria:

          -  age under 18

          -  pregnancy

          -  corticoid treatment before study entry

          -  adrenal insufficiency

          -  hypophyseal insufficiency

          -  treatment with etomidate one week before study entry

          -  participating in an other study

          -  no informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stepani Bendel, MD</last_name>
    <role>Study Director</role>
    <affiliation>Kuopio University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Esko Ruokonen, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Kuopio University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jyrki Tenhunen, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Tampere UH</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anna-Maija Antman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere UH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <zip>70211</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 7, 2008</study_first_submitted>
  <study_first_submitted_qc>May 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 9, 2008</study_first_posted>
  <last_update_submitted>April 3, 2015</last_update_submitted>
  <last_update_submitted_qc>April 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kuopio University Hospital</investigator_affiliation>
    <investigator_full_name>Stepani Bendel</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>brain death</keyword>
  <keyword>subarachnoid hemorrhage</keyword>
  <keyword>traumatic brain injury</keyword>
  <keyword>brain injury</keyword>
  <keyword>intracerebral hemorrhage</keyword>
  <keyword>organ donation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Death</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Cortisol succinate</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

